These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 13542827)

  • 21. [Treatment of South America blastomycosis of pulmonary localization with 6-sulfanilamido-2,4-dimethylpyrimidine; diagnosis & clinical evolution].
    PASSOS FILHO MC; NAHAS L
    Hospital (Rio J); 1959 Feb; 55(2):237-63. PubMed ID: 13640539
    [No Abstract]   [Full Text] [Related]  

  • 22. [Physicochemical and biological studies on sulfonamides. 3. Relation between some physicochemical properties of sulfonamides and their fate in human and animal bodies].
    RIEDER J
    Arzneimittelforschung; 1963 Feb; 13():95-103. PubMed ID: 13982263
    [No Abstract]   [Full Text] [Related]  

  • 23. A mechanistical model for the uptake of sulfonamides by bacteria.
    Zarfl C; Matthies M; Klasmeier J
    Chemosphere; 2008 Jan; 70(5):753-60. PubMed ID: 17765286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quaternary ammonium chitosan derivative dynamic coating for the separation of veterinary sulfonamide residues by CE with field-amplified sample injection.
    Ma M; Zhang HS; Xiao LY; Xiao L; Wang P; Cui HR; Wang H
    Electrophoresis; 2007 Nov; 28(22):4091-100. PubMed ID: 17960537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation.
    Mohan R; Banerjee M; Ray A; Manna T; Wilson L; Owa T; Bhattacharyya B; Panda D
    Biochemistry; 2006 May; 45(17):5440-9. PubMed ID: 16634625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties.
    Chazalette C; Masereel B; Rolin S; Thiry A; Scozzafava A; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5781-6. PubMed ID: 15501040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular structure and dynamic properties of a sulfonamide derivative of glutathione that is produced under conditions of oxidative stress by hypochlorous acid.
    Harwood DT; Nimmo SL; Kettle AJ; Winterbourn CC; Ashby MT
    Chem Res Toxicol; 2008 May; 21(5):1011-6. PubMed ID: 18447396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
    Lehtonen JM; Parkkila S; Vullo D; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3757-62. PubMed ID: 15203157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
    Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides.
    Remko M; von der Lieth CW
    Bioorg Med Chem; 2004 Oct; 12(20):5395-403. PubMed ID: 15388166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.
    Zimmerman S; Innocenti A; Casini A; Ferry JG; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6001-6. PubMed ID: 15546717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AN UNUSUAL CASE OF BACTERIAL ENDOCARDITIS IN AN INFANT WITH CONGENITAL HEART DISEASE.
    CAYLER GG; TASSOPOULOS NM
    Calif Med; 1963 Oct; 99(4):260-3. PubMed ID: 14054222
    [No Abstract]   [Full Text] [Related]  

  • 33. QSAR study on carbonic anhydrase inhibitors: water-soluble sulfonamides incorporating beta-alanyl moieties, possessing long lasting-intra ocular pressure lowering properties--a molecular connectivity approach.
    Agrawal VK; Banerji M; Gupta M; Singh J; Khadikar PV; Supuran CT
    Eur J Med Chem; 2005 Oct; 40(10):1002-12. PubMed ID: 15961191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental study on the effects of pharmaco-serum of diabetic rats fed with Chinese herbs qianggubao decoction ([Chinese characters: see text]) on osteoblast culture in vitro].
    Su YX; Zheng LP; Chen ZN; Yang LZ; Wang HM
    Zhongguo Gu Shang; 2008 Mar; 21(3):190-3. PubMed ID: 19105435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.
    Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
    Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new synthesis of sulfonamides by aminolysis of p-nitrophenylsulfonates yielding potent and selective adenosine A2B receptor antagonists.
    Yan L; Bertarelli DC; Hayallah AM; Meyer H; Klotz KN; Müller CE
    J Med Chem; 2006 Jul; 49(14):4384-91. PubMed ID: 16821798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytotoxic properties and structure of sulfapyridine compounds].
    MANSKI W; ZAWISZA W
    Med Dosw Mikrobiol; 1958; 10(3):377-83. PubMed ID: 13600012
    [No Abstract]   [Full Text] [Related]  

  • 39. [Observations on cryptogenic feverets; importance of pharmaco-dynamic tests in their identification].
    BELLIENI G; LANZONI E
    Acta Paediatr Lat; 1953; 6(4):839-52. PubMed ID: 13147869
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of pharmaco-dynamic potentiation in psychiatric diagnosis].
    BENASSI P; CANESTRARI R
    Riv Sper Freniatr Med Leg Alien Ment; 1955 Mar; 79(1):45-70. PubMed ID: 14396214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.